Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009

In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Blain, Amy E., Mandal, Sema, Wu, Henry, MacNeil, Jessica R., Harrison, Lee H., Farley, Monica M., Lynfield, Ruth, Miller, Lisa, Nichols, Megin, Petit, Sue, Reingold, Arthur, Schaffner, William, Thomas, Ann, Zansky, Shelley M., Anderson, Raydel, Harcourt, Brian H., Mayer, Leonard W., Clark, Thomas A., Cohn, Amanda C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047430/
https://www.ncbi.nlm.nih.gov/pubmed/27704009
http://dx.doi.org/10.1093/ofid/ofw152
Descripción
Sumario:In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practices may inform future meningococcal disease management guidelines.

Ejemplares similares